awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53737270-CBDDF2C9-716C-42C5-BA16-0901B32D7049
Q53737270-CBDDF2C9-716C-42C5-BA16-0901B32D7049
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53737270-CBDDF2C9-716C-42C5-BA16-0901B32D7049
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.
P1476
Q53737270-CBDDF2C9-716C-42C5-BA16-0901B32D7049
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53737270-CBDDF2C9-716C-42C5-BA16-0901B32D7049
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb2dca70e081a42e297ddceec8a67c500af84e0e
P1476
Rechallenge of docetaxel combi
......
single-institution experience.
@en